Advertisement · 728 × 90
#
Hashtag
#aaaai2025
Advertisement · 728 × 90
Image of a person coughing as they look up their diagnosis on a pollution emitting computer running AI. Showing the pollution created by "AI doctors" cause the diseases they claim to identify.

Image of a person coughing as they look up their diagnosis on a pollution emitting computer running AI. Showing the pollution created by "AI doctors" cause the diseases they claim to identify.

For those that attended day 1 of #AAAAI #AAAAI2025 🤣. I made Gemini make fun of itself but still needed photoshop because of course.

0 0 0 0
Post image Post image

So proud of our team for representing our division at the American Academy of Allergy, Asthma, & Immunology Conference last month! They brought back valuable insights and ideas, despite the tempting San Diego weather. ☀️🧪
#TeamScience #AAAAI2025

1 0 0 0
Preview
Skin Monitoring Could Make Oral Food Challenge Safer Pilot study suggests dermatology tool might give early warning of when to stop dosing

"Food challenges are very safe, but the perception is that they can be dangerous." -- George Freigeh, MD, of the University of Michigan, discussing a research tool that may help #allergists stop an oral food challenge before #anaphylaxis onset. #aaaai2025
www.medpagetoday.com/meetingcover...

0 0 1 0
Post image

Congrats to Hill Lab post-doc Liv for her excellent poster presentation on how #diet influences risk of #asthma! #AAAAI #AAAAI2025

2 0 0 0
Post image

Lycia Therapeutics’ leadership will attend the 2025 AAAAI/WAO Joint Congress in San Diego, Feb 28 – Mar 3.

We’re excited to discuss the latest in allergy & immunology R&D and share how our LYTAC platform is shaping the future of targeted protein degradation. Let’s connect at #AAAAI2025!

4 1 0 0
Post image

Over half of CSU patients on advanced therapy needed add-on treatment or switched meds, and 26% on omalizumab exceeded FDA-approved doses—highlighting the need for better options. #AAAAI2025

www.hcplive.com/view...

0 0 0 0
Post image

New study @NJHealth finds infant’s cheek skin barrier dysfunction predicts #AtopicDermatitis. The research links delayed filaggrin processing, low ceramides & high IL-18 to AD risk. #AAAAI2025

www.hcplive.com/view...

0 0 0 0